Proton Pump Inhibitors (PPIs): Pharmacy Medication Guide

Understanding Proton Pump Inhibitors

Proton pump inhibitors (PPIs) are among the most frequently prescribed and dispensed medications in pharmacy practice. These drugs suppress gastric acid production and are used to treat conditions including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. For PTCB exam preparation, pharmacy technicians need a thorough understanding of PPI medications.

PPIs are consistently one of the top drug classes dispensed in both retail and hospital pharmacies. Several PPIs are also available over the counter, making them a common topic for patient questions at the pharmacy counter.

How PPIs Work

Proton pump inhibitors work by irreversibly blocking the hydrogen-potassium ATPase enzyme system (the proton pump) in the parietal cells of the stomach lining. This enzyme is responsible for the final step of acid secretion into the stomach. By blocking this pump, PPIs reduce gastric acid production by up to 99%, providing more effective and longer-lasting acid suppression than H2 receptor antagonists like famotidine or ranitidine.

Because PPIs block the proton pump irreversibly, the body must produce new proton pumps before acid secretion returns to normal. This is why PPIs provide sustained acid suppression and why it may take several days to reach full therapeutic effect.

Common PPI Medications

All PPIs share the common stem "-prazole," which makes them easy to identify. The following are the PPIs currently available in the United States.

• Omeprazole (Prilosec) - available both by prescription and OTC
• Esomeprazole (Nexium) - the S-isomer of omeprazole, available by prescription and OTC
• Lansoprazole (Prevacid) - available by prescription and OTC
• Dexlansoprazole (Dexilant) - prescription only, extended-release formulation
• Pantoprazole (Protonix) - the most commonly used IV PPI in hospitals
• Rabeprazole (AcipHex) - prescription only

Combination Products

Several combination products include PPIs. Omeprazole is combined with sodium bicarbonate in Zegerid for faster onset of action. Esomeprazole is combined with naproxen in Vimovo to reduce the gastrointestinal side effects of the NSAID. Knowing these combinations helps pharmacy technicians identify therapeutic duplications during the dispensing process.

Clinical Uses of PPIs

Gastroesophageal Reflux Disease (GERD)

GERD is the most common indication for PPI therapy. PPIs are recommended as first-line treatment for moderate to severe GERD symptoms and for healing erosive esophagitis. Standard treatment courses typically last 4 to 8 weeks, though some patients require long-term maintenance therapy.

Peptic Ulcer Disease

PPIs are essential in treating both gastric and duodenal ulcers. When ulcers are caused by Helicobacter pylori infection, PPIs are used as part of a combination regimen (triple therapy or quadruple therapy) that includes antibiotics such as amoxicillin and clarithromycin. PPIs are also used to prevent and treat ulcers caused by NSAIDs.

Zollinger-Ellison Syndrome

This rare condition causes excessive gastric acid production due to tumors (gastrinomas). PPIs are the treatment of choice, often at higher doses than used for GERD or ulcer therapy.

Important Side Effects

While PPIs are generally well tolerated for short-term use, long-term therapy has been associated with several important side effects that pharmacy technicians should know.

• Increased risk of Clostridioides difficile (C. diff) infection due to reduced stomach acid
• Decreased absorption of calcium, magnesium, iron, and vitamin B12
• Potential increased risk of bone fractures with long-term use
• Possible increased risk of kidney disease with prolonged therapy
• Common minor side effects include headache, diarrhea, nausea, and abdominal pain
• Rebound acid hypersecretion when stopping long-term PPI therapy abruptly

Drug Interactions

PPIs have several clinically significant drug interactions that are commonly tested on the PTCB exam. Omeprazole and esomeprazole inhibit the CYP2C19 enzyme, which can increase blood levels of certain medications. The interaction between omeprazole and clopidogrel (Plavix) is particularly important because it may reduce the antiplatelet effect of clopidogrel.

PPIs can also reduce the absorption of drugs that require an acidic stomach environment. These include certain antifungal medications like ketoconazole and itraconazole, some HIV medications like atazanavir and rilpivirine, and iron supplements. Patients taking these medications should be counseled about proper timing and spacing of doses.

Administration and Counseling Points

Most PPIs should be taken 30 to 60 minutes before a meal, ideally before breakfast, for optimal effectiveness. The delayed-release capsules should be swallowed whole and not crushed or chewed, as the enteric coating protects the medication from degradation in stomach acid. For patients who cannot swallow capsules, some PPIs can be opened and sprinkled on applesauce or mixed into water.

OTC vs. Prescription PPIs

Over-the-counter PPIs are approved for the treatment of frequent heartburn (two or more days per week). OTC labeling typically recommends use for only 14 days, with a repeat course allowed after 4 months. Prescription PPIs are used for more serious conditions and may be prescribed at higher doses or for longer durations. Pharmacy technicians should know which PPIs are available OTC and their approved indications.

PTCB Exam Tips

For the PTCB exam, memorize all PPI brand and generic names and the "-prazole" stem. Understand the key drug interactions, especially with clopidogrel. Know that PPIs should be taken before meals and that long-term use carries risks of nutrient deficiencies. Being able to distinguish between PPI and H2 blocker medications is also important for exam success.